The Passing of Steve Jobs: A Statement from the Pancreatic Cancer Action Network
MANHATTAN BEACH, Calif., Oct. 5, 2011 /PRNewswire/ -- The following is a statement in response to the death of Steve Jobs from Julie Fleshman , President and CEO of the Pancreatic Cancer Action Network, the national organization fighting pancreatic cancer in a comprehensive way through research, patient support, community outreach and advocacy for a cure.
"We extend our deepest sympathy to the family of Steve Jobs , his friends and colleagues, and the entire Apple community. He was an American icon and among the greatest visionaries of our time, taken too soon.
"While Steve Jobs battled a rare form of pancreatic cancer (pancreatic neuroendocrine tumor), his passing, if due to pancreatic cancer, is a stark reminder of the severity of this deadly cancer and lack of effective treatment options available to patients. Even those with the greatest access to treatments and the highest level of care cannot defeat this insidious disease.
"It's time to make pancreatic cancer a national priority and give patients a fighting chance. We invite all those inspired by this great man to join the Pancreatic Cancer Action Network in the fight against this devastating disease. We must come together to know, fight and end pancreatic cancer."
To learn more about the Pancreatic Cancer Action Network and all forms of pancreatic cancer, visit www.pancan.org.
About the Pancreatic Cancer Action Network
The Pancreatic Cancer Action Network is the national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization is leading the way to increase the survival rate for people diagnosed with this devastating disease through a bold initiative — The Vision of Progress: Double the Pancreatic Cancer Survival Rate by 2020. Together, we can know, fight and end pancreatic cancer by intensifying our efforts to heighten awareness, raise funds for comprehensive private research, and advocate for dedicated federal research to advance early diagnostics, better treatments and increase chances of survival.
SOURCE Pancreatic Cancer Action Network
More by this Source
Researchers Funded By The Pancreatic Cancer Action Network Leverage $9.15 Million Investment By The Organization Into $91 Million In Subsequent Pancreatic Cancer Research Funding
May 15, 2013, 09:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.